| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 42.969 | 57.396 | 65.025 | 73.979 | 84.847 | 119.343 | 143.449 | - | - | - |
| Total Income - EUR | 42.970 | 57.400 | 65.030 | 73.981 | 84.848 | 119.346 | 143.485 | - | - | - |
| Total Expenses - EUR | 14.611 | 18.930 | 18.372 | 21.220 | 58.125 | 55.214 | 57.296 | - | - | - |
| Gross Profit/Loss - EUR | 28.360 | 38.471 | 46.658 | 52.761 | 26.723 | 64.132 | 86.189 | - | - | - |
| Net Profit/Loss - EUR | 27.070 | 37.897 | 46.008 | 52.021 | 25.874 | 63.028 | 84.754 | - | - | - |
| Employees | 6 | 6 | 7 | 4 | 4 | 4 | 4 | - | - | - |
Check the financial reports for the company - Mialga Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 5.197 | 5.194 | 63.189 | 40.677 | - | - | - |
| Current Assets | 19.182 | 43.745 | 47.586 | 93.185 | 65.807 | 66.575 | 71.186 | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Receivables | 19.123 | 35.294 | 41.952 | 91.360 | 64.190 | 29.003 | 3.470 | - | - | - |
| Cash | 59 | 8.450 | 5.634 | 1.825 | 1.617 | 37.572 | 67.716 | - | - | - |
| Shareholders Funds | 17.962 | 42.315 | 46.060 | 97.235 | 71.670 | 88.461 | 84.802 | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | - | - | - |
| Debts | 1.219 | 1.430 | 1.526 | 1.147 | 1.520 | 43.779 | 27.061 | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mialga Med Srl